Lipid Mediators: Advancements and Approaches | FASEB

Having provided the latest in lipid mediator research for 23 years, this conference will focus on new developments in the area of lysophospholipid signaling, particularly lysophosphatidic acid (LPA), sphingosine 1-phosphate (S1P), ceramides (Cer) and specialized pro-resolving lipid mediators (SPM).

The program will cover the role of lipid mediators in immunology, neurobiology, metabolic and cardiovascular diseases, cancer, and microbiology. It will also feature recent advances and findings regarding their signaling and function, clinical applications, analytical and diagnostic approaches, pathophysiology cell biology, and biochemistry. Early-career researchers and those from historically excluded groups are especially encouraged to attend and present their findings.